ENLV icon

Enlivex Therapeutics

10 hedge funds and large institutions have $5.53M invested in Enlivex Therapeutics in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
5
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
SM
1
Sabby Management
Florida
$2.82M +$2.82M +28,348 New
VAM
2
Visium Asset Management
New York
$1.78M -$325K -3,259 -15%
KCM
3
Knoll Capital Management
Florida
$625K -$217K -2,179 -26%
OC
4
Oppenheimer & Co
New York
$155K -$40.7K -410 -21%
HighTower Advisors
5
HighTower Advisors
Illinois
$86K
VKH
6
Virtu KCG Holdings
New York
$54K +$28.1K +283 +108%
UBS Group
7
UBS Group
Switzerland
$4K -$12.5K -131 -76%
LTFS
8
Ladenburg Thalmann Financial Services
Florida
$2K
TRCT
9
Tower Research Capital (TRC)
New York
$1K -$5.5K -33 -85%
SIM
10
Spark Investment Management
New York
-$108K -701 Closed
Walleye Trading
11
Walleye Trading
New York
-$2K -10 Closed
Wells Fargo
12
Wells Fargo
California
-$1K -8 Closed
Citigroup
13
Citigroup
New York
-$1K -7 Closed